Core Points - Shenzhen Zhizheng High Polymer Materials Co., Ltd. plans to acquire the equity and control of Advanced Assembly Materials International Limited through a major asset swap, issuance of shares, and cash payment, while divesting 100% equity of Shanghai Zhizheng New Materials Co., Ltd. [1][2] - The China Securities Regulatory Commission (CSRC) has approved the company's registration application for issuing shares to purchase assets and raise supporting funds, with a total of 29 million shares to be issued to ASMPT Hong Kong Holding Limited and other investors [1][2] - The company is authorized to raise up to 1 billion yuan in supporting funds through the issuance of shares [2] Regulatory Approval - The CSRC's approval is valid for 12 months from the date of issuance [2] - The company must comply with relevant regulations and timely disclose information regarding the transaction [2] - The board of directors will handle the related matters within the stipulated timeframe and ensure compliance with disclosure obligations [2]

Major Events - Kweichow Moutai's controlling shareholder obtained a loan of 2.7 billion yuan to increase holdings [1] - SMIC is actively promoting the purchase of 49% equity in SMIC North, but the transaction plan is still under discussion [1] - Guokai Microelectronics is advancing the issuance of shares and cash payment for asset acquisition and fundraising [1] - Aerospace Hongtu signed a strategic cooperation agreement with Pakistan, but the formal contract signing remains uncertain [1] - Sinopec announced a cash dividend of 0.088 yuan per share (before tax) for A-shares [1] - Hikvision's chairman proposed a mid-2025 dividend plan of 4 yuan for every 10 shares [1] - Anzheng Fashion reported no undisclosed major events [1] - China State Construction is acquiring equity in a Shanghai real estate project for approximately 15.478 billion yuan [1] - Guokai Co., Ltd. changed its stock name to Guokai Electronics [1] - Kailuan Co. completed the change in the equity structure of China Cinda [1] - Unification Co. completed the change in the equity structure of its controlling shareholder [1] - ST Xin Dongli's stock may face delisting risk warning [1] - Jinlang Technology reported normal recent operations with no significant changes in the internal and external environment [1] - Sungrow Power Supply confirmed normal operations with no undisclosed major events [1] - Tiantong Co. reported normal production and operations with no significant changes [1] - Keyuan Pharmaceutical received a decision letter on the anti-monopoly review without further examination [1] - Zhizheng Co. was approved to issue shares for asset acquisition and fundraising [1] - Amlogic plans to issue H-shares and list on the Hong Kong Stock Exchange [1] - Digital Certification's controlling shareholder changed to Beijing Data Group [1] - ST Songfa signed a contract for two 30.6 million-ton ultra-large crude oil tankers with Hengli Shipbuilding [1] - Guangqi Technology signed a contract worth 1.278 billion yuan for the mass production of metamaterials [1] - Hongrun Construction won a bid for the Ningbo Ring City South Road East Extension Phase I project with a bid price of 388 million yuan [1] Performance - Muyuan Foods reported sales revenue of 11.85 billion yuan from live pigs in August, a year-on-year decrease of 12.30% [1] - Ankai Bus's cumulative production increased by 68.06% this year [1] - Shuguang Co. reported a 45.58% increase in axle sales in August [1] - Jinxinnong reported sales revenue of 121 million yuan from live pigs in August [1] Buyback - Yingke Medical adjusted the upper limit of its share repurchase price from 26.51 yuan per share to 41.88 yuan per share [2]

Core Viewpoint - The company plans to acquire the equity and control of Advanced Packaging Materials International Limited through a significant asset swap, issuance of shares, and cash payment, while divesting 100% of Shanghai Zhizheng New Materials Co., Ltd. and raising supporting funds [1] Group 1 - The company received approval from the China Securities Regulatory Commission on September 5, 2025, for the issuance of shares to purchase assets and raise supporting funds [1] - The company is authorized to issue shares to multiple companies for the acquisition of related assets [1] - The company is allowed to raise supporting funds not exceeding 1 billion yuan [1]

Core Viewpoint - The company plans to acquire the equity and control of Advanced Packaging Materials International Co., Ltd. through a significant asset swap, issuance of shares, and cash payment, while divesting 100% equity of Shanghai Zhizheng New Materials Co., Ltd. and raising supporting funds [1] Group 1 - The company received approval from the China Securities Regulatory Commission on September 5, 2025, for the issuance of shares to purchase assets and raise supporting funds [1] - The company is authorized to issue shares to multiple companies for the acquisition of related assets [1] - The company is allowed to raise supporting funds not exceeding 1 billion yuan [1]

Core Viewpoint - The company intends to acquire the equity and control of Advanced Packaging Materials International Limited through a significant asset swap, issuance of shares, and cash payment, while divesting 100% equity of Shanghai Zhizheng New Materials Co., Ltd. and raising supporting funds [1] Group 1 - The company received approval from the China Securities Regulatory Commission on September 5, 2025, for the issuance of shares to purchase assets and raise supporting funds [1] - The company plans to issue shares to multiple companies for the acquisition of related assets [1] - The company is authorized to raise up to 1 billion yuan through the issuance of shares [1]

证券代码：603991 证券简称：至正股份 公告编号：2025-052 深圳至正高分子材料股份有限公司 关于重大资产置换、发行股份及支付现金购买资产并 募集配套资金暨关联交易事项获得中国证券监督管 理委员会同意注册批复的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 深圳至正高分子材料股份有限公司（以下简称"公司"）拟通过重大资产置 换、发行股份及支付现金的方式取得先进封装材料国际有限公司（Advanced Assembly Materials International Limited）的股权及其控制权、置出上海至正新材 料有限公司 100%股权并募集配套资金（以下简称"本次交易"）。 公司于 2025 年 9 月 5 日收到中国证券监督管理委员会出具的《关于同意深 圳至正高分子材料股份有限公司发行股份购买资产并募集配套资金注册的批复》 （证监许可〔2025〕1965 号）（以下简称"中国证监会批复"）。中国证监会 批复文件的主要内容如下： "一、同意你公司向 ASMPT Hong Kong Holding Limit ...

Core Viewpoint - The A-share market shows a mixed performance with the Shanghai Composite Index closing above the six-month moving average, indicating potential bullish sentiment among investors [1] Group 1: Market Overview - As of 13:59 today, the Shanghai Composite Index stands at 3814.20 points, with a decline of 1.14% [1] - The total trading volume in the A-share market reached 1,878.28 billion yuan [1] Group 2: Stocks Breaking the Six-Month Moving Average - Thirteen A-shares have surpassed the six-month moving average today, with notable stocks including Renfu Pharmaceutical, Guofeng New Materials, and Zhizheng Co., which have deviation rates of 8.65%, 4.92%, and 4.08% respectively [1] - Stocks with smaller deviation rates that have just crossed the six-month moving average include Jinbo Biological, ST Huawen, and *ST Zhongzhuang [1] Group 3: Individual Stock Performance - Renfu Pharmaceutical (600079) experienced a price increase of 9.99% with a turnover rate of 8.87%, closing at 22.57 yuan, showing a deviation rate of 8.65% from the six-month moving average [1] - Guofeng New Materials (000859) rose by 6.13% with a turnover rate of 9.75%, closing at 7.10 yuan, reflecting a deviation rate of 4.92% [1] - Zhizheng Co. (603991) saw a 4.74% increase with a turnover rate of 4.15%, closing at 63.48 yuan, with a deviation rate of 4.08% [1]

Core Viewpoint - The A-share market shows a mixed performance with the Shanghai Composite Index closing at 3820.98 points, slightly below the previous close, and a total trading volume of 1.472 trillion yuan, indicating a cautious market sentiment [1] Group 1: Market Performance - The Shanghai Composite Index closed at 3820.98 points, with a decline of 0.96% [1] - The total trading volume in the A-share market reached 1.472 trillion yuan [1] Group 2: Stocks Breaking Half-Year Line - A total of 10 A-shares have surpassed the half-year line today, with notable stocks including Renfu Pharmaceutical, Guofeng New Materials, and *ST Sihuan showing significant deviation rates of 8.65%, 6.97%, and 3.30% respectively [1] - Stocks with smaller deviation rates that just crossed the half-year line include Yiatong, Sifang Co., and Meike Home, indicating a more cautious upward movement [1] Group 3: Individual Stock Performance - Renfu Pharmaceutical (600079) saw a price increase of 9.99% with a turnover rate of 7.60%, closing at 22.57 yuan, with a deviation rate of 8.65% from the half-year line [1] - Guofeng New Materials (000859) increased by 8.22% with a turnover rate of 8.12%, closing at 7.24 yuan, showing a deviation rate of 6.97% [1] - *ST Sihuan (000518) rose by 3.46% with a turnover rate of 2.24%, closing at 2.39 yuan, with a deviation rate of 3.30% [1]

Financial Performance - The company's total operating revenue is 104 million yuan, an increase of 5.92 million yuan compared to the same period last year, marking three consecutive years of growth, with a year-on-year increase of 6.03% [1] - The net profit attributable to shareholders is -22.648 million yuan [1] - The net cash inflow from operating activities is 11.2302 million yuan, an increase of 41.2116 million yuan compared to the same period last year [1] Profitability and Efficiency - The latest gross profit margin is 9.67%, an increase of 3.15 percentage points from the previous quarter [4] - The latest return on equity (ROE) is -11.05% [4] - The diluted earnings per share are -0.30 yuan [5] - The latest total asset turnover ratio is 0.17 times, an increase of 0.01 times compared to the same period last year, representing a year-on-year increase of 3.80% [5] - The latest inventory turnover ratio is 1.75 times, ranking 37th among disclosed peer companies, with an increase of 0.78 times compared to the same period last year, reflecting a year-on-year increase of 80.40% [5] Shareholder Structure - The number of shareholders is 13,000, with the top ten shareholders holding 25.9723 million shares, accounting for 34.85% of the total share capital [5] - The largest shareholder is Shenzhen Zhengxin Tongchuang Investment Development Co., Ltd., holding 27.00% [5]

Core Viewpoint - Zhizheng Co., Ltd. reported a revenue increase but a significant decline in profit for the first half of 2025, indicating challenges in maintaining profitability despite higher sales [1]. Financial Performance - The total revenue for the first half of 2025 reached 104 million yuan, a year-on-year increase of 6.03% compared to 98.25 million yuan in 2024 [1]. - The net profit attributable to shareholders was -22.648 million yuan, reflecting a year-on-year decline of 266.1% from -6.1863 million yuan in 2024 [1]. - The gross profit margin decreased to 9.67%, down 57.47% from 22.73% in the previous year [1]. - The net profit margin fell to -26.44%, a decrease of 370.59% from -5.62% in 2024 [1]. - Total expenses (selling, administrative, and financial) amounted to 27.6826 million yuan, accounting for 26.57% of revenue, which is an increase of 21.23% year-on-year [1]. Cash Flow and Debt - The cash flow per share was 0.15 yuan, showing a significant increase of 137.46% from -0.4 yuan in the previous year [1]. - The company’s cash and cash equivalents decreased by 50.45% to 21.4526 million yuan [1]. - The interest-bearing debt was reported at 123 million yuan, a reduction of 15.15% from 145 million yuan in 2024 [1]. Historical Performance - The company has a median Return on Invested Capital (ROIC) of 6.9% since its listing, with a particularly poor performance in 2021, where ROIC was -11.7% [3]. - Historically, the company has reported losses in 6 out of 7 annual reports since its IPO, indicating a trend of poor financial performance [3]. Recommendations - Attention is advised on the company's cash flow situation, as the ratio of cash to current liabilities is only 44.91%, and the average operating cash flow over the past three years has been negative [3]. - The company’s debt situation is concerning, with an interest-bearing asset liability ratio reaching 20.62% and negative average operating cash flow over the past three years [3]. - Monitoring of accounts receivable is recommended, given the negative net profit attributable to shareholders in the annual report [3].